Log in to save to my catalogue

Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based...

Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f66621292ae74a88b19c2f9e43bf0d56

Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial

About this item

Full title

Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2009-10, Vol.7 (1), p.60-60, Article 60

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Suicidal thoughts and behaviours during antidepressant treatment, especially during the first weeks of treatment, have prompted warnings by regulatory bodies. The aim of the present study is to investigate the course and predictors of emergence and worsening of suicidal ideation during tricyclic antidepressant and serotonin reuptake inhibitor treat...

Alternative Titles

Full title

Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f66621292ae74a88b19c2f9e43bf0d56

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f66621292ae74a88b19c2f9e43bf0d56

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/1741-7015-7-60

How to access this item